Grohs J G, Fischer G, Raberger G
Abteilung für Herz-Kreislauf-Pharmakologie, Universität Wien, Austria.
Naunyn Schmiedebergs Arch Pharmacol. 1990 May;341(5):472-5. doi: 10.1007/BF00176342.
Stimulation of 5-HT1A receptors is known to decrease the arterial blood pressure in anaesthetized rats, cats and dogs. We investigated the hypotensive activity of flesinoxan (0.1 + 0.2 + 0.7 mumol/kg), a 5-HT1A-receptor agonist, in dogs anaesthetized with either morphine and pentobarbital or enflurane and also in the conscious state. Flesinoxan led to a decrease in arterial blood pressure in anaesthetized, but not in conscious dogs. In the conscious state the marked increase in heart rate, which can be taken as an indicator of sympathetic tone, may have masked the consequences of vasodilatation. These different haemodynamic responses to flesinoxan may be dependent on side effects of the drug in the conscious dogs, in particular hyperventilation and salivation combined with anxiety, and on the magnitude of the decrease in baroreceptor reflex activity during anaesthesia with morphine and pentobarbital on the one hand and enflurane on the other hand.
已知刺激5-HT1A受体可降低麻醉大鼠、猫和狗的动脉血压。我们研究了5-HT1A受体激动剂氟司必林(0.1 + 0.2 + 0.7 μmol/kg)在用吗啡和戊巴比妥或恩氟烷麻醉的狗以及清醒状态下的降压活性。氟司必林可使麻醉狗的动脉血压降低,但对清醒狗无效。在清醒状态下,心率显著增加,这可作为交感神经张力的指标,可能掩盖了血管舒张的后果。对氟司必林的这些不同血液动力学反应可能取决于该药物对清醒狗的副作用,特别是过度通气和流涎并伴有焦虑,以及一方面取决于吗啡和戊巴比妥麻醉期间压力感受器反射活动的降低幅度,另一方面取决于恩氟烷麻醉期间压力感受器反射活动的降低幅度。